Silence Therapeutics plc reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was GBP 5.72 million compared to GBP 3.14 million a year ago. Net loss was GBP 7.68 million compared to GBP 8.42 million a year ago. Basic loss per share from continuing operations was GBP 0.086 compared to GBP 0.097 a year ago.